Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 3/2014

Open Access 01-05-2014 | Poster presentation

Comparative evaluation of baseline characteristics of HIV mono infected and HIV/HBV co infected cohort in eastern India

Authors: Jayeeta Sarkar, Debraj Saha, Bibhuti Saha, Bhaswati Bandyopadhyay, Runu Chakrabarty, Subhasish Kamal Guha

Published in: BMC Infectious Diseases | Special Issue 3/2014

Login to get access

Excerpt

India has the third largest estimated number of HIV infected people and 40 million individuals in India are estimated to be Hepatitis B virus infected. In comparison to HBV mono-infection, the course of chronic HBV infection is more accelerated in HIV/HBV co-infected subjects. We analyzed the baseline characteristics of the HIV/HBV co-infected and HIV mono-infected patients. …
Metadata
Title
Comparative evaluation of baseline characteristics of HIV mono infected and HIV/HBV co infected cohort in eastern India
Authors
Jayeeta Sarkar
Debraj Saha
Bibhuti Saha
Bhaswati Bandyopadhyay
Runu Chakrabarty
Subhasish Kamal Guha
Publication date
01-05-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue Special Issue 3/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-S3-P14

Other articles of this Special Issue 3/2014

BMC Infectious Diseases 3/2014 Go to the issue

Poster presentation

Human cytomegalovirus glycoprotein N polymorphisms among renal transplant recipients in India

ePoster presentation

In silco analysis of carboxamide derivatives of piperidine as potential antagonists of CCR5

Poster presentation

A study to determine and compare the knowledge, attitude and compliance of Tuberculosis treatment among HIV seropositive and HIV seronegative TB patients

ePoster presentation

Comparative codon usage analysis of HIV-1 and HIV-2 genomes

Poster presentation

Prevalence of HBV infection in immunocompromised patients on ART nearly equals HBV mono infection in individuals not infected with HIV, Shimla Northern India

Poster presentation

Cloning, expression and purification of Chikungunya virus E2 recombinant protein in E.coli
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits